BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20261031T155129Z - 18685@eupv304
DTSTART;TZID=Europe/Brussels:20261128T083000
DTEND;TZID=Europe/Brussels:20261128T140000
CREATED:20261031T155129Z
DESCRIPTION:<a href="https://www.analis.com/event/belsaci-symposium-2026-28
 8/register">BelSACI SYMPOSIUM 2026</a>\nBelSACI SYMPOSIUM 2026 Organised b
 y the Belgian Society for Allergy and Clinical Immunology (BELSACI) Saturd
 ay\, 28 November 2026\, at The Faculty Club\, Leuven\, from 8:30 a.m. to 2
  p.m. The main topic will be ANAPHYLAXIS.THE PROGRAM TIME PROGRAMME 08:30 
 – 8:55 Opening\, coffee and breakfast 08:55 – 9:00 Welcome and introdu
 ction Prof Dr Antoine Froidure\, UCLouvain · BelSACI Chair PART I | Burde
 n and new concepts in anaphylaxis\, including economic aspects Moderators:
  Dr Xavier Van Der Brempt and Prof Dr Christine Breynaert · Category VI r
 equested 09:00 – 9:45 Old allergens\, new foods\, changing risks: the fu
 ture of food anaphylaxis. Prof Clare Mills\, University of Surrey\, UK 09:
 45 – 10:05 ORAL ABSTRACTS · Four selected presentations (titles to be a
 nnounced) 10:10 – 10:40 Tryptase revisited – a paradigm change Dr Drie
 s Wets\, KU Leuven 10:40 – 11:35 Coffee break and snacks PART II | Updat
 e in anaphylaxis management Moderators: Prof Virginie Doyen and Dr Valéri
 e Pékus 11:35 – 11:55 ORAL ABSTRACTS · Four selected presentations (ti
 tles to be announced) 12:00 – 12:30 New forms of epinephrine: the presen
 t and the future of anaphylaxis management in children Dr Sarah De Schryve
 r\, AZ Sint-Lucas\, Ghent PART III | BelSACI General Assembly 12:30 – 13
 :00 BelSACI General Assembly and election results 13:00 – 13:15 Final re
 marks\, prizes and closing of the meeting Come to discover our new innovat
 ive solutions in the field of allergy research: A Next-Generation Basophil
  Activation Test (BAT) for research use only\, designed to more effectivel
 y characterise food allergies without exposure to potentially harmful alle
 rgens. Approximately 220 million people globally suffer from at least one 
 food allergy. Most food allergies and treatment efficacies are currently d
 etermined through a dated and rigorous Oral Food Challenge (OFC)\, which e
 xposes patients to gradual amounts of food to determine [...]
DTSTAMP:20261031T155129Z
LOCATION:Groot Begijnhof 14\, 3000 Leuven\, Belgium
SUMMARY:BelSACI SYMPOSIUM 2026
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.analis.com/event/belsaci-
 symposium-2026-288/register">BelSACI SYMPOSIUM 2026</a>\nBelSACI SYMPOSIUM
  2026 Organised by the Belgian Society for Allergy and Clinical Immunology
  (BELSACI) Saturday\, 28 November 2026\, at The Faculty Club\, Leuven\, fr
 om 8:30 a.m. to 2 p.m. The main topic will be ANAPHYLAXIS.THE PROGRAM TIME
  PROGRAMME 08:30 – 8:55 Opening\, coffee and breakfast 08:55 – 9:00 We
 lcome and introduction Prof Dr Antoine Froidure\, UCLouvain · BelSACI Cha
 ir PART I | Burden and new concepts in anaphylaxis\, including economic as
 pects Moderators: Dr Xavier Van Der Brempt and Prof Dr Christine Breynaert
  · Category VI requested 09:00 – 9:45 Old allergens\, new foods\, chang
 ing risks: the future of food anaphylaxis. Prof Clare Mills\, University o
 f Surrey\, UK 09:45 – 10:05 ORAL ABSTRACTS · Four selected presentation
 s (titles to be announced) 10:10 – 10:40 Tryptase revisited – a paradi
 gm change Dr Dries Wets\, KU Leuven 10:40 – 11:35 Coffee break and snack
 s PART II | Update in anaphylaxis management Moderators: Prof Virginie Doy
 en and Dr Valérie Pékus 11:35 – 11:55 ORAL ABSTRACTS · Four selected 
 presentations (titles to be announced) 12:00 – 12:30 New forms of epinep
 hrine: the present and the future of anaphylaxis management in children Dr
  Sarah De Schryver\, AZ Sint-Lucas\, Ghent PART III | BelSACI General Asse
 mbly 12:30 – 13:00 BelSACI General Assembly and election results 13:00 
 – 13:15 Final remarks\, prizes and closing of the meeting Come to discov
 er our new innovative solutions in the field of allergy research: A Next-G
 eneration Basophil Activation Test (BAT) for research use only\, designed 
 to more effectively characterise food allergies without exposure to potent
 ially harmful allergens. Approximately 220 million people globally suffer 
 from at least one food allergy. Most food allergies and treatment efficaci
 es are currently determined through a dated and rigorous Oral Food Challen
 ge (OFC)\, which exposes patients to gradual amounts of food to determine 
 [...]
END:VEVENT
END:VCALENDAR